Identification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic Fibrosis

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorOspedale San Raffaele

About this trial

In this project the investigators aim to identify new biological markers by characterizing the response/inflammation associated with the development and progression of M. abscessus lung disease in patients suffering from cystic fibrosis with the aim of increasing current knowledge available on the development and progression of lung disease.

Eligibility criteria

Qualifiers

Patients with a certain diagnosis of cystic fibrosis and visited during normal clinical practice, in accordance with the standard operating procedures in force at the Centres.

Both sexes

Age >18 years

Obtaining informed consent for patients (based on the procedures established by the protocol).

Disqualifiers

Patients unable to understand the instructions and information provided and be able to adequately accept the study methods.

Trial design

Treatments tested in this trial

  • Luminex; scRNAsec

Treatment groups

40 Participants
are divided into 4 treatment groups

Sponsors and collaborators

Ospedale San Raffaele

Lead sponsor

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Collaborator